Back to Search Start Over

106O Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial.

Authors :
Califano, R
Hochmair, M J
Gridelli, C
Delmonte, A
Campelo, M R Garcia
Bearz, A
Griesinger, F
Morabito, A
Felip, E
Ghosh, S
Tiseo, M
Haney, J
Kerstein, D
Popat, S
Camidge, D R
Source :
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p. 1 Chart.
Publication Year :
2019

Subjects

Subjects :
*ANAPLASTIC lymphoma kinase
*NON-small-cell lung carcinoma

Details

Language :
English
ISSN :
09237534
Volume :
30
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
136076478
Full Text :
https://doi.org/10.1093/annonc/mdz063.004
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details